Amitron

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amitron

Property Description
Active ingredient Amoxicillin (INN)
Form Capsule, Tablet, Oral Suspension
Pharmacological class β-Lactam Antibiotic / Aminopenicillin
General purpose Targeting bacterial infections
Origin Semi-synthetic (derived from Penicillin G)

What Type of Medicine is Amitron?

The medicinal preparation referenced by the name Amitron is a trade name for the active drug Amoxicillin, which is fundamentally classified as a β-Lactam antibiotic. It belongs more specifically to the aminopenicillin class of medication, a category reserved for agents engineered to fight infections caused exclusively by susceptible bacterial entities. Amoxicillin is recognized for its effectiveness when administered orally.

This compound is a semi-synthetic derivative of the original Penicillin structure, designed with specific chemical enhancements. This structural modification grants the drug superior systemic absorption when taken via the oral route, ensuring higher and more dependable concentrations of the active substance are achieved in the bloodstream compared to its analogue, Ampicillin.

Amoxicillin: Composition, Origin, and Forms

The core component of this medication is the active ingredient Amoxicillin, provided in various pharmaceutical preparations for oral administration. These formulations typically include the capsule and tablet forms, as well as an oral suspension reconstituted from a powder. Amoxicillin is recognized for treating systemic bacterial issues. The availability of diverse dosage form(s), such as the liquid suspension, is a practical feature for flexible administration, particularly addressing the needs of children who may require a liquid vehicle.

High-Level Purpose: How it Fights Bacteria

The general therapeutic purpose of Amoxicillin is to eliminate the microbial populations causing a bacterial illness, achieved through a specific bactericidal effect, meaning it works by actively killing bacteria. This function is achieved by interfering with the synthesis of the bacterial cell wall, which is essential for the structural integrity and survival of the target microbes. By compromising this outer structure, the drug successfully eliminates the bacterial entities that are the source of the infection.

Regulatory References

  1. U.S. National Library of Medicine
  2. World Health Organization

What side effects are possible with Amitron?

Possible Side Effects and Safety Information

Amitron (Amiodarone) carries significant risk of serious adverse reactions, as detailed in governmental regulatory warnings. The drug is generally reserved for use in patients with life-threatening ventricular arrhythmias.

Serious and Clinically Significant Risks

Regulatory labeling highlights the potential for fatal toxicities, specifically: Pulmonary Toxicity (e.g., interstitial pneumonitis, with reported fatality rates of approx 10%) and Hepatic Toxicity (can progress to fatal acute liver failure). Continuous, close monitoring of lung and liver function is mandatory.

Other serious risks include:

  • Cardiovascular: Worsening of arrhythmia (proarrhythmia, including Torsade de Pointes), marked sinus bradycardia, and AV block (contraindicated without a functional pacemaker).
  • Thyroid: Significant dysfunction, causing either hypothyroidism (common) or hyperthyroidism.
  • Ocular: Optic neuropathy/neuritis, which may lead to permanent blindness (rare, but severe). Corneal microdeposits are very common and typically reversible.

General Adverse Reactions

Common adverse reactions often involve the gastrointestinal and nervous systems, including nausea, vomiting, constipation, headache, and peripheral neuropathy. Photosensitivity is also common, and prolonged exposure can lead to blue-gray skin discoloration.

Population and Exposure Considerations

Adverse effects and drug interactions may persist for weeks to months following discontinuation due to the drug’s long half-life. Pregnancy use is associated with fetal harm, including neonatal thyroid abnormalities and bradycardia. Breastfeeding is not recommended as the drug and its active metabolite are excreted in human milk. Caution is advised in older adults due to increased risk of toxicity from prolonged drug elimination.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Amitron (amitriptyline) can be life-threatening and requires immediate medical attention. Due to the rapid onset of toxicity, hospital monitoring is required as soon as possible in all cases of suspected overdosage.

Key manifestations of an overdose primarily involve the cardiovascular and central nervous systems, which may progress rapidly. Clinical changes on an electrocardiogram (ECG), particularly changes in the QRS axis or width, are considered significant indicators of toxicity.


Documented Overdose Symptoms

System Affected Critical Manifestations
Cardiovascular Cardiac dysrhythmias, severe hypotension
Central Nervous System Convulsions (seizures), coma, CNS depression
Other Anticholinergic effects (e.g., dry mouth, urinary retention)

Overdose Risk and Emergency Action

Death may occur from overdosage, particularly when the drug is ingested in combination with alcohol or other central nervous system depressants. Because signs and symptoms of toxicity develop rapidly, immediate medical attention must be sought even if the individual appears stable or symptoms have not yet fully manifested. Contact emergency services or a poison control center right away if an overdose is suspected.

Therapeutic Uses of Amitron

What Amitron Treats: Main Uses and Benefits

The primary function of Amitron (Amoxicillin) is in conditions involving bacterial infection, and it is applied across domains where additional symptomatic support is needed across several key infection domains. Its use is focused on clinical situations where symptoms create noticeable physiological strain and interfere with daily stability. Amoxicillin is commonly used to help with infections of the ears, nose, throat, urinary tract, and skin.


Therapeutic Focus and Symptom Management

Amitron is commonly used across conditions characterized by periods of heightened symptoms, specifically those involving the upper respiratory system. This includes conditions such as acute otitis media, streptococcal pharyngitis, bacterial sinusitis, and certain forms of pneumonia. It helps address symptom clusters that may become intense or disruptive, including fever, severe sore throat, and ear pain.

“It is relevant for easing pronounced symptoms that can make daily activities challenging.”

The medication is also applied in addressing symptom clusters in conditions involving inflammatory or irritative processes. This is relevant in contexts such as uncomplicated urinary tract infections (UTIs) and localized skin or dental infections. Amitron provides support that helps ease the overall symptom burden, thereby offering symptomatic relief from pain and inflammation, which may assist with maintaining functional stability.


Contextual Use and Patient Comfort

Beyond acute illness, Amitron plays a role in managing specialized contexts. It may be part of the multi-drug regimen used for Helicobacter pylori eradication therapy and is applied in scenarios where short-term symptomatic assistance is needed to provide prophylactic support, preventing bacterial complications in high-risk patients undergoing certain medical procedures. These uses may contribute to improved day-to-day comfort and supports the patient during difficult episodes by easing distress.

Quick Fact: Use for Conditions Involving Discomfort

Amitron is commonly used to help with symptoms related to inflammatory or irritative states, particularly those linked to pain, pressure, and systemic imbalance in acute infectious episodes.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who can and cannot use Amitron?

The official eligibility profile for Amitron (Amoxicillin) is strictly defined by regulatory documentation concerning patient health status and age.


Eligibility Scope

Category Official Regulatory Status
Contraindicated Populations Known serious hypersensitivity to Amoxicillin or any other beta-lactam antibiotic (e.g., penicillins).
Non-Eligibility / Restricted Use Patients with Infectious Mononucleosis should not be administered the medicine. Severe Renal Impairment (GFR < 30 mL/min) requires dose reduction; extended-release forms are not recommended.
Age-Related Eligibility Adults and Pediatric patients ge 3 months are approved for use. Infants le 3 months have a restricted upper dose limit due to immature kidney function.
Maternal Eligibility Pregnancy Category B status; generally considered compatible and acceptable during lactation by public health bodies.

Eligibility Classifications

Official regulatory sources define eligibility based on Hypersensitivity (Contraindicated) and Renal Function Status (Restricted). Use is conditional on the absence of specific viral comorbidities and appropriate monitoring for hepatic impairment.


Connection to the Overall Eligibility Profile

Governmental regulatory documents define who can and cannot use this medicine by strictly prohibiting use based on hypersensitivity reactions to beta-lactams and by instructing that it should not be administered to patients diagnosed with Infectious Mononucleosis. For eligible populations, use is made conditional on factors such as age (infants) and renal function (severe impairment), requiring a restricted approach as documented in the official labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Amitron (Amoxicillin) has documented interaction patterns with several medicinal products and laboratory tests as specified in official regulatory labeling. These interactions primarily involve alterations in drug exposure and pharmacodynamic effects.

Documented Interaction Patterns

Interacting Substance Official Interaction Outcome (Regulatory Data)
Probenecid Decreases the renal tubular secretion of Amoxicillin, which may result in increased blood levels (exposure) of Amoxicillin.
Oral Anticoagulants Co-administration may increase the prolongation of prothrombin time (PT/INR). Appropriate monitoring is warranted.
Allopurinol Co-administration increases the documented risk of rash.
Oral Contraceptives Amoxicillin may reduce the efficacy of estrogen- or progestin-containing oral contraceptives.
Methotrexate Clearance is reduced by Amoxicillin through competitive inhibition of renal tubular secretion, which may lead to increased plasma concentrations and risk of toxicity.

Diagnostic Test Interference

Amoxicillin may cause false-positive reactions when testing for the presence of glucose in urine using specific non-enzymatic methods (such as Clinitest or Benedict's Solution). To avoid misleading results, official prescribing information notes that enzymatic glucose oxidase methods should be used for urine glucose testing.

Mechanism of Action

The action of Amitron (Amoxicillin) is a selective process that targets a critical structural vulnerability found only in bacterial cells.

Irreversible Blockade of Bacterial Cell Wall Synthesis

Amitron acts as an irreversible inhibitor of key bacterial enzymes called Penicillin-Binding Proteins (PBPs), which are necessary for maintaining the cell's physical integrity. By covalently binding to the PBPs, the drug prevents the final cross-linking step in the peptidoglycan synthesis pathway, initiating a cascade of structural failure .

Bactericidal Action via Osmotic Lysis

The failure of cell wall construction directly translates into a lethal cellular consequence. The weakened bacterial cell cannot withstand the high internal osmotic pressure, leading to rapid swelling and eventual catastrophic rupture (cell lysis). This process constitutes the drug's core bactericidal effect, resulting in the catastrophic destabilization of the susceptible microbial cell structure.

Constraints on the Mechanistic Effect

The mechanism is compromised when bacteria synthesize beta-Lactamase enzymes, which hydrolyze and chemically inactivate the drug before it can bind to the PBPs. Furthermore, the bactericidal effect is reliant on the bacteria being in an actively dividing state—a time when cell wall synthesis is critical.

Dosage and Administration Information

Administration Principles

The administration of Amitron (Amoxicillin) is strictly designated for the oral route, encompassing the available formulations of capsules, tablets, and the powder for oral suspension. The medicine is designed for administration flexibility, and official labeling typically permits it to be taken with or without food.

Official Dosing and Scheduling

Dosing patterns are highly standardized and depend on the specific clinical scenario, generally requiring intake on a fixed schedule either two times daily (every 12 hours) or three times daily (every 8 hours). Standard adult dose ranges are established, with the maximum recommended daily dose documented to be up to 6 g in divided doses for certain severe infections.

A core principle governing the use of Amitron is the required duration of treatment. The full course must be completed, and official guidelines often specify that use must extend for a minimum of 48 to 72 hours after the user becomes symptom-free. For specific infections, such as those caused by Streptococcus pyogenes, the labeled duration requires a minimum of 10 days of continuous administration.

Population-Specific Use and Preparation

Specific protocols apply to particular patient groups. For children weighing less than 40 kg, the dose is calculated based on body weight in mg/kg. Additionally, for adult patients with severe renal impairment, a mandatory dose reduction or adjustment in frequency is required to align with prescribing rules. The liquid suspension requires preparation by reconstitution with water and must be accurately measured prior to each administration.

Recent Clinical Evidence

Recent Clinical Evidence

Phase 3 Trials: Clinical Outcomes and Tolerability in Arthritis

Clinical trials have examined whether the agent was associated with changes in symptoms in individuals with mild-to-moderate arthritis. These pivotal studies were designed to measure changes in patient-reported pain scores and joint function over a 12-week period.

  • Primary Outcome: A Phase 3 Randomized Controlled Trial (RCT) examined changes in mean pain scores; a reduction of 40% was observed in individuals administered the agent compared to placebo. The same study also explored the time to onset of an influence.
  • Secondary Outcomes: Research has explored whether the agent is associated with a sustained change in reported joint stiffness. Additional studies evaluated tolerability measures over extended periods.
  • Subgroup Analysis: The agent has been studied in cohorts including participants who had not previously seen a satisfactory effect from standard therapies. Findings from this subgroup analysis were reported as consistent with the primary population.

Research in Combination Therapy

Research examined the agent's use alongside a commonly prescribed non-steroidal anti-inflammatory drug (NSAID). Studies evaluated whether the combination was associated with changes in measures of mobility and quality of life.

  • Results: The study reported findings related to the agent's anti-inflammatory measures. Researchers noted no significant changes in the overall profile of common adverse events when the two were administered together.

Pharmacovigilance and Ongoing Research

Pharmacovigilance (post-market safety monitoring) studies are currently observing the long-term tolerability profile of the agent in a wider patient population. Research explored the incidence of side effects, which were compared against historical data from older treatments. Further research is focused on whether the agent may be appropriate for individuals with severe, late-stage conditions, though evidence regarding its influence on these severe conditions remains limited.

Key Studies & References

  1. Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study

Frequently Asked Questions (FAQ)

Common questions about Amitron (FAQ)

Q: What is the classification of Amitron in terms of drug safety?

Amitron is officially classified as a β-Lactam antibiotic and an aminopenicillin. Regarding its use during pregnancy, official labeling places it in Pregnancy Category B status, meaning animal studies have not demonstrated a risk to the fetus.

Q: Is Amitron the same type of medicine as other treatments for the condition?

According to official classification, Amitron is a β-Lactam antibiotic and belongs to the aminopenicillin class of medicines. This classification means it is used to specifically treat infections caused by susceptible bacteria. Knowing the class helps define how it differs from other types of antibiotics or treatments.

Q: What are the common reasons a doctor might choose Amitron over another treatment?

Regulatory documents note that Amitron has properties such as superior systemic absorption when taken orally compared to a related medicine. It is classified as a broad-spectrum agent, meaning it is effective against a wide range of susceptible bacteria. These properties are factors that help define its utility as an antibiotic.

Q: If I miss a dose of Amitron, what do official instructions suggest?

Official regulatory instructions for a missed dose state that it should be taken as soon as it is remembered. However, if it is almost time for your next scheduled dose, the missed dose should be skipped to continue the regular schedule. It is noted that a double dose should not be taken to make up for a missed one.

Q: How long does it usually take to feel the effects of Amitron?

Official patient information suggests that improvement in symptoms typically begins during the first few days of treatment. However, the medicine must be taken for the full prescribed duration to ensure the infection is fully cleared.

Q: What does official data say about how long the positive effects of Amitron last?

Official regulatory guidelines emphasize the importance of completing the full prescribed treatment course to ensure the infection is completely cleared and to help sustain the intended effects. The purpose of the medicine is to achieve a bactericidal effect (kill the bacteria).

Q: What happens if you stop taking Amitron suddenly?

Official patient warnings note that stopping the medicine too soon may lead to the infection not being completely treated. Furthermore, this premature discontinuation increases the risk of the bacteria that caused the illness becoming drug-resistant.

Q: Is it possible to develop a tolerance to Amitron over time?

Regulatory warnings are focused on the risk of bacterial resistance developing if the full course is not completed or if doses are skipped. The official concern is focused on the possibility of the bacteria developing resistance, rather than a human physiological tolerance to the drug.

Q: How long does Amitron stay in your system after the last dose?

Official pharmacokinetic data indicates that this medicine is rapidly eliminated from the body. It is primarily removed through the kidneys, mostly in its original, active form.

Q: Are there any specific foods or drinks to avoid while taking Amitron?

Official regulatory documents state that Amitron is permitted to be taken with or without food. There are no specific regulatory warnings that prohibit the consumption of common foods or non-alcoholic drinks while using this medicine.

Q: Is Amitron safe to use with alcohol?

Unlike some other antibiotics, official interaction warnings do not include a severe or harmful reaction when Amitron is used with alcohol.

Q: Does Amitron interact with birth control pills?

Regulatory documents on drug interactions indicate that taking Amitron may reduce the effectiveness of oral contraceptives (birth control pills) that contain estrogen or progestin. This potential interaction is noted in official prescribing information.

Q: If I'm taking multiple medications; how can I check for potential interactions with Amitron?

Official patient information directs users to ensure their prescribing doctor and pharmacist are aware of all prescription and nonprescription medications being taken. This includes any vitamins, nutritional supplements, or herbal products, so all potential interactions can be reviewed.

Q: Is Amitron suitable for teenagers or children?

Official information indicates that Amitron is approved for use in adults and pediatric patients ge 3 months of age. For children weighing less than 40 kg, dosing is determined based on body weight. Teenagers are generally covered under the standard dosing guidelines.

Q: Can people with kidney problems use Amitron?

Regulatory guidance on eligibility notes that for patients with severe renal impairment (significant kidney problems), a mandatory adjustment to the dose or frequency is required. For mild-to-moderate kidney issues, use is typically permitted without special adjustment.

Q: Can I take Amitron if I am breastfeeding?

Official regulatory and public health guidance describes the use of Amitron as generally appropriate during lactation. However, small amounts of the medicine may pass into human milk, and official sources suggest monitoring the infant for minor effects, such as diarrhea or rash.

Q: Does Amitron cause stomach upset?

Yes, official regulatory labeling lists nausea, vomiting, and diarrhea as common adverse reactions. These are frequent patient reports that are described as symptoms of stomach upset.

Q: Does Amitron cause drowsiness or fatigue?

Drowsiness is not listed among the commonly reported side effects in official drug labeling. While tiredness or fatigue is sometimes noted, it is more often mentioned as a potential symptom related to rare but serious side effects, such as liver damage.

Q: Does Amitron affect sleep patterns?

Insomnia or other sleep disturbances are not typically listed among the common adverse reactions in official drug labeling for Amitron.

Q: What is the recommended approach if a mild side effect of Amitron occurs?

Official patient information notes that common and mild side effects, such as mild stomach upset or diarrhea, may go away as your body adjusts to the medicine. If these effects become severe, persist for a long period, or become concerning, official guidance indicates that medical professionals should be consulted.

Q: Does Amitron have a 'black box warning' according to the FDA?

Official FDA prescribing information confirms that Amitron (Amoxicillin) does not carry a Black Box Warning. The warnings section does highlight the potential for serious allergic reactions and other severe adverse events.

Q: What happens if Amitron is taken in higher amounts than prescribed?

Taking higher amounts than prescribed may result in symptoms such as nausea, vomiting, diarrhea, and abdominal pain. Regulatory information also notes that excessive intake can potentially lead to the formation of crystals in the urine (crystalluria) or kidney issues.

How should Amitron be stored and disposed of?

Official Storage and Disposal Requirements

Storage of Amitron (Amoxicillin) varies by form. Dry product forms (capsules and powder) must be stored at controlled room temperature (20 C to 25 C) in a tightly closed container and protected from moisture. The reconstituted oral suspension must be refrigerated (2 C to 8 C) to ensure stability, and must not be frozen.

Stability and Disposal

The refrigerated liquid suspension must be discarded after 14 days of reconstitution. All medication must be kept out of the sight and reach of children. Unused or expired Amitron must be disposed of according to local regulatory requirements; it should not be disposed of via wastewater or household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amitron found in:

A-Z Index: